EIF4EBP1
برای مطالعهٔ بیشتر

Armengol G, Rojo F, Castellví J, Iglesias C, Cuatrecasas M, Pons B, Baselga J, Ramón y Cajal S (2007). "4E-binding protein 1: a key molecular "funnel factor" in human cancer with clinical implications". Cancer Res. 67 (16): 7551–7555. doi:10.1158/0008-5472.CAN-07-0881. PMID 17699757.
Mader S, Lee H, Pause A, Sonenberg N (1995). "The translation initiation factor eIF-4E binds to a common motif shared by the translation factor eIF-4 gamma and the translational repressors 4E-binding proteins". Mol. Cell. Biol. 15 (9): 4990–7. doi:10.1128/MCB.15.9.4990. PMC 230746. PMID 7651417.
Haystead TA, Haystead CM, Hu C, Lin TA, Lawrence JC (1994). "Phosphorylation of PHAS-I by mitogen-activated protein (MAP) kinase. Identification of a site phosphorylated by MAP kinase in vitro and in response to insulin in rat adipocytes". J. Biol. Chem. 269 (37): 23185–91. doi:10.1016/S0021-9258(17)31637-X. PMID 8083223.
Haghighat A, Mader S, Pause A, Sonenberg N (1996). "Repression of cap-dependent translation by 4E-binding protein 1: competition with p220 for binding to eukaryotic initiation factor-4E". EMBO J. 14 (22): 5701–9. doi:10.1002/j.1460-2075.1995.tb00257.x. PMC 394685. PMID 8521827.
Feigenblum D, Schneider RJ (1996). "Cap-binding protein (eukaryotic initiation factor 4E) and 4E-inactivating protein BP-1 independently regulate cap-dependent translation". Mol. Cell. Biol. 16 (10): 5450–7. doi:10.1128/MCB.16.10.5450. PMC 231545. PMID 8816458.
Rousseau D, Gingras AC, Pause A, Sonenberg N (1997). "The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth". Oncogene. 13 (11): 2415–20. PMID 8957083.
Tsukiyama-Kohara K, Vidal SM, Gingras AC, Glover TW, Hanash SM, Heng H, Sonenberg N (1997). "Tissue distribution, genomic structure, and chromosome mapping of mouse and human eukaryotic initiation factor 4E-binding proteins 1 and 2". Genomics. 38 (3): 353–363. doi:10.1006/geno.1996.0638. PMID 8975712.
Fadden P, Haystead TA, Lawrence JC (1997). "Identification of phosphorylation sites in the translational regulator, PHAS-I, that are controlled by insulin and rapamycin in rat adipocytes". J. Biol. Chem. 272 (15): 10240–10247. doi:10.1074/jbc.272.15.10240. PMID 9092573.
Brunn GJ, Fadden P, Haystead TA, Lawrence JC (1998). "The mammalian target of rapamycin phosphorylates sites having a (Ser/Thr)-Pro motif and is activated by antibodies to a region near its COOH terminus". J. Biol. Chem. 272 (51): 32547–32550. doi:10.1074/jbc.272.51.32547. PMID 9405468.
Burnett PE, Barrow RK, Cohen NA, Snyder SH, Sabatini DM (1998). "RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1". Proc. Natl. Acad. Sci. U.S.A. 95 (4): 1432–1437. doi:10.1073/pnas.95.4.1432. PMC 19032. PMID 9465032.
New L, Jiang Y, Zhao M, Liu K, Zhu W, Flood LJ, Kato Y, Parry GC, Han J (1998). "PRAK, a novel protein kinase regulated by the p38 MAP kinase". EMBO J. 17 (12): 3372–3384. doi:10.1093/emboj/17.12.3372. PMC 1170675. PMID 9628874.
Heesom KJ, Avison MB, Diggle TA, Denton RM (1999). "Insulin-stimulated kinase from rat fat cells that phosphorylates initiation factor 4E-binding protein 1 on the rapamycin-insensitive site (serine-111)". Biochem. J. 336 (1): 39–48. doi:10.1042/bj3360039. PMC 1219839. PMID 9806882.
Waskiewicz AJ, Johnson JC, Penn B, Mahalingam M, Kimball SR, Cooper JA (1999). "Phosphorylation of the cap-binding protein eukaryotic translation initiation factor 4E by protein kinase Mnk1 in vivo". Mol. Cell. Biol. 19 (3): 1871–80. doi:10.1128/MCB.19.3.1871. PMC 83980. PMID 10022874.
Seeley TW, Wang L, Zhen JY (1999). "Phosphorylation of human MAD1 by the BUB1 kinase in vitro". Biochem. Biophys. Res. Commun. 257 (2): 589–595. doi:10.1006/bbrc.1999.0514. PMID 10198256.
Gingras AC, Gygi SP, Raught B, Polakiewicz RD, Abraham RT, Hoekstra MF, Aebersold R, Sonenberg N (1999). "Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism". Genes Dev. 13 (11): 1422–1437. doi:10.1101/gad.13.11.1422. PMC 316780. PMID 10364159.
Yang D, Brunn GJ, Lawrence JC (1999). "Mutational analysis of sites in the translational regulator, PHAS-I, that are selectively phosphorylated by mTOR". FEBS Lett. 453 (3): 387–390. doi:10.1016/S0014-5793(99)00762-0. PMID 10405182. S2CID 5023204.
Kim ST, Lim DS, Canman CE, Kastan MB (2000). "Substrate specificities and identification of putative substrates of ATM kinase family members". J. Biol. Chem. 274 (53): 37538–37543. doi:10.1074/jbc.274.53.37538. PMID 10608806.
Mothe-Satney I, Yang D, Fadden P, Haystead TA, Lawrence JC (2000). "Multiple mechanisms control phosphorylation of PHAS-I in five (S/T)P sites that govern translational repression". Mol. Cell. Biol. 20 (10): 3558–3567. doi:10.1128/MCB.20.10.3558-3567.2000. PMC 85648. PMID 10779345.
Mothe-Satney I, Brunn GJ, McMahon LP, Capaldo CT, Abraham RT, Lawrence JC (2000). "Mammalian target of rapamycin-dependent phosphorylation of PHAS-I in four (S/T)P sites detected by phospho-specific antibodies". J. Biol. Chem. 275 (43): 33836–33843. doi:10.1074/jbc.M006005200. PMID 10942774.